Washington’s Senate Bill 5660
For The Psychedelics as Medicine Report: Fourth Edition, PSYCH spoke with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
In March, the Washington State legislature passed Senate Bill 5660, directing Washington State Health Care Authority to assess the provision of psilocybin services.
State officials have created a working group to evaluate the socioeconomic benefits of an adult-use psilocybin programme.
This working group must deliver a preliminary report on its findings to the Washington State Governor by December, with a full report submitted by the end of 2023.
Assuming the results of the report are positive, psilocybin could be available in Washington as early as 2026.READ MORE